Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score N/A
- Piotroski Score N/A
- Grade N/A
- Symbol (YS)
- Company YS Biopharma Co., Ltd.
- Price $1.02
- Changes Percentage (9.68%)
- Change $0.09
- Day Low $0.90
- Day High $1.10
- Year High $1.78
YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. It develops a proprietary PIKA immunomodulating technology platform and a series of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, and Shingles. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was founded in 2002 and is based in Beijing, China.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 08/20/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.56
- Trailing P/E Ratio -1.82
- Forward P/E Ratio -1.82
- P/E Growth -1.82
- Net Income $-145,479,105
Income Statement
Quarterly
Annual
Latest News of YS
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Meta Platforms, Inc. (META) Receives Buy Rating from Pivotal Research, Analyst Highlights Strong Growth Potential with 3.3 Billion Users
Discover the latest in AI news with Meta Platforms' standing among other AI stocks. Learn about Equinix's joint venture for AI data centers, US government funding for sustainable semiconductor materia...
By Yahoo! Finance | 8 hours ago -
Ryan Murphy says 'Monsters: The Erik and Lyle Menendez story' is the best thing to happen to the brothers in decades. There is one way the show could help their case.
Ryan Murphy's show on the Menendez brothers could help their case by unearthing compelling evidence. Legal experts believe media attention, like in other true crime cases, could potentially lead to ne...
By Business Insider | 9 hours ago -
Crystal Palace v Liverpool: Premier League - live
Crystal Palace have struggled to win in the Premier League this season, while Liverpool is dominating the table. Despite Liverpool's history of success at Selhurst Park, Palace could break their strea...
By The Guardian | 9 hours ago